Scholars Central

Mini reviewPublished 5 Mar 2018

Autoimmune Mechanisms of Psoriasis: Pathogenic Role of the IL-23/IL-17 Axis

Authors: Melanie Wolf, Alex Shnyra

Journal of Autoimmune Disorders

Volume 4 · Issue 1 · Pages 05

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Psoriasis is a chronic, recurrent, immuno-inflammatory disease of the skin and joints associated with significant morbidity and mortality. Psoriasis affects approximately 2-4% of the Caucasian population worldwide. The precise immuno-inflammatory mechanisms leading to skin psoriasis are still to be fully defined. There is emerging evidence supporting the existence of a relationship between changes in cutaneous microbiota and development of psoriasis. Under certain pathologic conditions associated with dysbiosis of the skin microbiome, pathogenic microbes triggering aberrant immuno-inflammatory responses may spark the onset and relapses of psoriasis. Strong association of certain human leukocyte antigens (HLAs) along with the pathogenic role of IL-17 suggests the involvement of autoimmune mechanisms in psoriasis. Multiple clinical trials targeting the IL-17/IL-23 axis in psoriasis are underway. Here, we review the emerging findings suggesting the autoimmune nature of psoriasis and examine new therapeutic approaches for treatment of this chronic immuno-inflammatory disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Autoimmune Disorders
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Melanie Wolf”
  • BylineArticles whose byline prints “Alex Shnyra”